Familial and sporadic Hodgkin's disease associated with occupational wood exposure

Tobacco and alcohol use and oral cancer in Puerto Rico.

Cancer causes & control : CCC·1999

Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark.

International journal of cancer·1999

Rising incidence of renal cell cancer in the United States.

JAMA·1999

Lipid-lowering medication and risk of cancer.

Journal of clinical epidemiology·1999

Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.

British journal of cancer·1999

Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.

British journal of cancer·1999

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

The Intersection of Psychological Distress, Cardiovascular Health, and Allostatic Load in Occupational Settings: Implications for Preventive Medicine, Occupational Health, and Clinical Management.

Medicina (Kaunas, Lithuania)·2026

Epidemiological and Laryngoscopic Characteristics of Head and Neck Burns Requiring Airway Evaluation: A Single-Center Retrospective Cohort.

Medicina (Kaunas, Lithuania)·2026

Emotional Exhaustion and Quiet Quitting Among Psychiatric Healthcare Workers: The Differential Mediating Roles of Emotional Labor Strategies.

Healthcare (Basel, Switzerland)·2026

Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study.

Biomedicines·2026

Unusual Switch of Cell Death Mode by Docosahexaenoic Acid (DHA) via Enhancing Endoplasmic Reticulum Peroxidation Induced by Lipophilic Iron Complex.

Antioxidants (Basel, Switzerland)·2026

Preoperative Antithrombotic Exposure and Postoperative Outcomes Following Nontraumatic Subdural Hematoma Evacuation: A Multicenter Electronic Health Record Analysis with Single-Center Context.

Brain sciences·2026

Related Experiment Videos

Familial and sporadic Hodgkin's disease associated with occupational wood exposure

Related Concept Videos

Tobacco and alcohol use and oral cancer in Puerto Rico.

Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark.

Rising incidence of renal cell cancer in the United States.

Lipid-lowering medication and risk of cancer.

Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.

Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

The Intersection of Psychological Distress, Cardiovascular Health, and Allostatic Load in Occupational Settings: Implications for Preventive Medicine, Occupational Health, and Clinical Management.

Epidemiological and Laryngoscopic Characteristics of Head and Neck Burns Requiring Airway Evaluation: A Single-Center Retrospective Cohort.

Emotional Exhaustion and Quiet Quitting Among Psychiatric Healthcare Workers: The Differential Mediating Roles of Emotional Labor Strategies.

Efferocytosis-Related Transcriptional Dysregulation in Hidradenitis Suppurativa Lesional Macrophages: A Multi-Cohort Single-Cell and Bulk Transcriptomic Study.

Unusual Switch of Cell Death Mode by Docosahexaenoic Acid (DHA) via Enhancing Endoplasmic Reticulum Peroxidation Induced by Lipophilic Iron Complex.

Preoperative Antithrombotic Exposure and Postoperative Outcomes Following Nontraumatic Subdural Hematoma Evacuation: A Multicenter Electronic Health Record Analysis with Single-Center Context.

Related Experiment Videos

Familial and sporadic Hodgkin's disease associated with occupational wood exposure

Related Concept Videos

Related Articles